Skip to main content

Banyai William's Form 4 filing

Twist Bioscience Corp (TWST) · filed Nov 23, 2021

Accession no.
0001214659-21-012191
Filed
Nov 23, 2021
Trade date
Nov 19-22, 2021
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 9 non-derivative transactions. Open-market sales total $2.03M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Banyai WilliamCIK 0001753670Director, Officer (See Remarks)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 19, 2021Common StockFTax withholdingDisposed−967$110.62−$106,969.54305,411Direct
Nov 22, 2021Common StockSSaleDisposed−300$96.97−$29,091305,111Direct
Nov 22, 2021Common StockSSaleDisposed−1,601$98.55−$157,778.55303,510Direct
Nov 22, 2021Common StockSSaleDisposed−1,892$99.73−$188,689.16301,618Direct
Nov 22, 2021Common StockSSaleDisposed−3,966$100.66−$399,217.56297,652Direct
Nov 22, 2021Common StockSSaleDisposed−3,926$101.81−$399,706.06293,726Direct
Nov 22, 2021Common StockSSaleDisposed−3,900$102.86−$401,154289,826Direct
Nov 22, 2021Common StockSSaleDisposed−1,967$103.78−$204,135.26287,859Direct
Nov 22, 2021Common StockSSaleDisposed−2,431$104.92−$255,060.52285,428Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Remarks

Senior Vice President of Advanced Development and General Manager of Data Storage

Read the full filing on SEC EDGAR (opens in a new tab)